Low molecular weight polycyclic aromatic hydrocarbons (LMW PAHs; < 206.3 g/mol) are prevalent and ubiquitous environmental contaminants, presenting a human health concern, and have not been as thoroughly studied as the high MW PAHs. LMW PAHs exert their pulmonary effects, in part, through P38-dependent and -independent mechanisms involving cellcell communication and the production of pro-inflammatory mediators known to contribute to lung disease. Specifically, we determined the effects of two representative LMW PAHs, 1-methylanthracene (1-MeA) and fluoranthene (Flthn), individually and as a binary PAH mixture on the dysregulation of gap junctional intercellular communication (GJIC) and connexin 43 (Cx43), activation of mitogen activated protein kinases (MAPK), and induction of inflammatory mediators in a mouse non-tumorigenic alveolar type II cell line (C10). Both 1-MeA, Flthn, and the binary PAH mixture of 1-MeA and Flthn dysregulated GJIC in a dose and time-dependent manner, reduced Cx43 protein, and activated the following MAPKs: P38, ERK1/2, and JNK. Inhibition of P38 MAPK prevented PAH-induced dysregulation of GJIC, whereas inhibiting ERK and JNK did not prevent these PAHs from dysregulating GJIC indicating a P38-dependent mechanism. A toxicogenomic approach revealed significant P38-dependent and -independent pathways involved in inflammation, steroid synthesis, metabolism, and oxidative responses. Genes in these pathways were significantly altered by the binary PAH mixture when compared with 1-MeA and Flthn alone suggesting interactive effects. Exposure to the binary PAH mixture induced the production and release of cytokines and metalloproteinases from the C10 cells. Our findings with a binary mixture of PAHs suggest that combinations of LMW PAHs may elicit synergistic or additive inflammatory responses which warrant further investigation and confirmation.
we breathe making the lung a direct target for adverse health effects.
A common source of PAHs is secondhand smoke, commonly referred to as environmental tobacco smoke (ETS) which affects both smokers and nonsmokers. Known adverse health effects of ETS exposure include inflammatory lung diseases such as asthma, emphysema, and chronic obstructive pulmonary disease (COPD) (He et al., 2012; Karimi et al., 2015; Oberg et al., 2011) . Cigarette smoking in the workplace elevates both particulate phase LMW PAHs and inflammatory proteins in the blood of non-smokers (Pacheco et al., 2013) . Decreased lung function in a Chinese population has also been associated with specific LMW PAH urinary metabolites of fluorene, phenanthrene, and pyrene (Zhou et al., 2015) .
The chemical family of PAHs can be grouped into high molecular weight (HMW PAHs) and low molecular weight (LMW PAHs) with the latter including 2-4 ring PAHs. Cigarette and marijuana smoke is a complex mixture including both high and LMW PAHs Moir et al., 2008) . Studies suggest that the total amount of LMW PAH released in ETS is $26,014 ng/cigarette. Comparably, only $1,307 ng/cigarette of HMW PAH (!5 ring) is released in ETS resulting in LMW PAHs representing $95% of the total PAH . According to these values, a pack a day smoker would be exposed to $3.6 mg of LMW PAHs after 1 week of smoking (Moir et al., 2008) . Combinations of PAHs could result in interactions which may be additive, antagonistic, or synergistic Upham et al., 2008; Wan et al., 2006) . Evaluating combinations of LMW PAHs with certain structural characteristics could reflect 'real world' exposures Rummel et al., 1999; Upham et al., 2008) . Thus, determining the potential mechanisms by which these non-genotoxic LMW PAHs can cause adverse health effects, such as inflammation, will contribute a better understanding on the toxic effects of environmental PAHs.
For our current studies, we used the non-tumorigenic C10 cell line, derived from alveolar type II pneumocytes (type II cells) in a BALB/c mouse that have been well characterized (Malkinson et al., 1997; Rice et al., 2010) . Type II cells are an epithelial cell critical in defense of the alveolar space from inhaled pollutants and maintenance of homeostasis. In addition, type II cells maintain gas exchange, secrete surfactant, have a metabolic capacity, and play a role in lung immunity through secretion of cytokines and chemokines (Mason, 2006) .
Gap junctions are important in the maintenance of tissue homeostasis and normal physiological processes that include eliciting appropriate immune responses. The most ubiquitous connexin, expressed by type II cells, prominent in connections between type II cells, and the main pulmonary gap junction protein is connexin 43 (Cx43) (Abraham et al., 2001) . Regulation of Cx43 can modulate inflammatory responses in lung disease models of cystic fibrosis, acute lung injury, and idiopathic pulmonary fibrosis (Chanson et al., 2001; Sarieddine et al., 2009; Trovato-Salinaro et al., 2006) . Our laboratory and others have previously shown that 1-methylanthracene (1-MeA) can dysregulate gap junctional intercellular communication (GJIC) through P38 MAPK, reduce Cx43 protein expression, and induce tumor necrosis factor (TNF) and prostaglandin-endoperoxide synthase 2 (Ptgs2) which is also commonly known as cyclooxygenase 2 (Cox-2) Rummel et al., 1999) . Thus, we further investigated MAPK pathways, with a focus on P38 MAP kinase and its role in LMW PAH induced pro-inflammatory genes and release of mediators.
P38 MAPK orchestrates an inflammatory signaling cascade resulting in cytokine release and has been considered a target in the treatment of COPD (Chung, 2011) . In a cigarette smoke model, inhibition of P38 can reduce levels of inflammatory mediators like Cox-2 and interleukin-6 (Il-6), and reduce neutrophilia and matrix metalloproteinases (Mmps) . All of these responses are associated with COPD and inflammatory lung diseases (Medicherla et al., 2008; Underwood et al., 2000) . In humans, phosphorylated P38 is significantly elevated in epithelial tissue from smokers and patients with COPD (Gaffey et al., 2013) .
Collectively, we hypothesized that lung epithelial cells exposed to single fluoranthene (Flthn), 1-methylanthracene (1-MeA), or a binary PAH mixture of Flthn and 1-MeA will have dysregulated cell-cell communication, activation of P38 MAPK, and elicit pro-inflammatory mediators, which could contribute to chronic lung pathologies such as COPD. Lastly, to further investigate the induction and release of pro-inflammatory mediators in response to the binary PAH mixture of 1-MeA and Flthn, we used a transcriptomic and proteomic approach to identify P38-dependent and -independent pathways.
MATERIALS AND METHODS
Materials and reagents. Fluoranthene (Flthn; purity 97.2%) and 1-MeA (purity 99.5%) were purchased from AccuStandard (New Haven, CT) and Crescent Chemical (Islandia, NY), respectively. Dimethyl sulfoxide (DMSO) and Lucifer Yellow were purchased from Sigma-Aldrich (St Louis, MO). Inhibitors of P38 (SB203580) and ERK1/2 (U0126) were purchased from Tocris Bioscience. The JNK inhibitor (JNK-II-8) was purchased from EMD Millipore (Billerica, MA). Stock solutions for PAHs and inhibitors of P38, ERK1/2, and JNK were prepared in DMSO.
Cell culture and treatment with LMW PAHs. The C10 mouse cell line was chosen because it is one of the best in vitro cell model systems of alveolar type II cells, which are recognized to be the progenitor/stem cell that gives rise to alveolar type I cells and self-renew. This cell line was extensively reviewed in Malkinson et al. (1997) . Alveolar type II cells are known to initiate and progress into lung cancer, particularly non-small cell lung carcinoma (NSCLC) (Desai et al., 2014; Lin et al., 2012) . The C10 cells are non-transformed cells that exhibit normal gap junctional intercellular communication (Chaudhuri et al., 1993) , and are naturally immortalized cells that were cloned from in vitro cellular outgrowths of explanted lungs of a BALB/c mouse (Bentel et al., 1989) . Surfactant proteins B and C are expressed in this cell line when treated with hypoxia induced mitogenic factor (Tong et al., 2006) . This cell line was obtained from Dr. Lori Dwyer Nield (University of Colorado Anschutz Medical Campus, Aurora, CO) and cultured in CMRL 1066 (Gibco, Thermo Fisher Scientific) containing 10% FBS and 1% glutamate in a humidified atmosphere at 37 C, 5% CO 2 , and 95% air (Malkinson et al., 1997) . Cells were grown to confluence (2-3 days) in a 35 mm diameter (SL/DT, RNA extraction) or 60mm diameter (protein extraction) tissue culture dish (Greiner, Cell Star, USA Scientific, Ocala, FL). At confluence, cells were serum-deprived for 24 h prior to treatment with the single 1-MeA or Flthn, or the binary mixture of 1-MeA and Fthln. Experiments were conducted at passage number 30 or less. 1-MeA and Flthn were dissolved in DMSO and applied directly to the plates from a concentrated stock solution. DMSO concentrations were below 0.01% for all treatments, did not elicit cytotoxicity to the cells, and no differences between a DMSO and media control were observed. The concentration of LMW PAH selected for these studies is based on the IC 50 for the dysregulation of GJIC at 30 min and 24 h. Therefore at the 30 min, 4 h, and 8 h time points, the 30 min IC 50 concentration was used. At the 24 h time point, the 24 h IC 50 concentrations were used. In Figures 1 and 2 , each single PAH (1-MeA or Flthn), and the binary PAH mixture of 1-MeA and Flthn IC 50 's were determined for these time points Moir et al., 2008) .
Scalpel-loaded dye transfer assay (SL/DT). Following the method described by (Upham, 2011) , cells were grown to confluence before three cuts were made with a steel scalpel blade in the presence of Lucifer Yellow (1 mg/ml in PBS), which was allowed to transfer through gap junctions for three minutes. Cells were then fixed with 4% formalin and the area of dye spread imaged with an Eclipse Ti-S microscope at 100Â. Affymetrix Mouse 2.0 array analysis. Total RNA was isolated from cells using the Nucleospin RNA II kit (Macherey-Nagel). RNA was then quality tested using an Agilent Tapestation Bioanalyzer (Agilent, Santa Clara, CA) and only those samples passing with a RIN of 7 or higher were used for the microarray studies and validation using qRTPCR analysis. Gene expression analysis was conducted using Affymetrix Mouse Gene 2.0 ST arrays, similar to previous studies . All array studies, including quality testing, amplification of total RNA, hybridization, and scanning of the arrays were performed at the Genomics and Microarray Core at the UCD Cancer Center, similar to that described in . The CEL files were preprocessed by computing the robust multi-array average (RMA) of background adjusted, quantile normalized, and log base 2 transformed perfect match (PM) intensity values (Irizarry et al., 2003a (Irizarry et al., , 2003b . Microarray analysis was performed using a twoway (treatment and time main effects) analysis of variance (ANOVA) model with an interaction term in Partek Genomics Suite v6.6 software to determine gene expression differences between the mean expression of treatment/time groups. The number of samples per group for the array study was n ¼ 3; control (DMSO) at 4 h was used for both time points. Differentially expressed genes (DEGs) were detected using a false discovery rate (FDR) < 0.05 (Benjamini and Hochberg, 1995) and absolute fold change > 1.5. The DEGs were then enriched for biological categories (FDR < 0.05) using gene ontology (GO) and KEGG pathway analysis in the Database for Annotation, Visualization, and Integrated Discovery (DAVID) v6.7 Bioinformatics resource (https://david.ncifcrf.gov; last accessed February 15, 2016). The raw data discussed in this publication have been deposited into NCBI Gene Expression Omnibus (GEO, http://www.ncbi.nlm .nih.gov/geo/, Series GSE84649) and used the "minimum information about a microarray experiment" as per NCBI standards. Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). One microgram of total RNA was reverse transcribed to cDNA (Bauer et al., 2011 (Bauer et al., , 2016 and amplified with gene-specific primers labeled with SYBR Green master mix (Kappa Biosystems, Wilmington, MA) using an Eppendorf Mastercycler ep Realplex (Eppendorf, Hauppauge, NY). Samples were normalized to the expression of 18S rRNA using the comparative CT method (Bookout et al., 2001; Hill et al., 2013) . Sequences for the primers can be found in Supplementary Table 1 .
RayBiotech cytokine array and enzyme linked immunosorbent assay (ELISA). Media from binary PAH mixture treated C10 cells was collected and analyzed for cytokines/chemokines by a Raybiotech Cytokine Array (AAM-CYT-G1000) and an ELISA for Cxcl1 (R&D Systems, Minneapolis, MN). The Raybiotech Mouse Cytokine Array was analyzed at Raybiotech, Inc, Norcross, GA. The Raybiotech protein array was performed with n ¼ 3 per treatment group. The manufacturer's instructions were followed for the Cxcl1 ELISA.
Statistics. All data are presented as the group mean 6 standard error of the mean (SE). For the SL/DT assays, cytotoxicity, immunoblots, qt-PCR, and Cxcl1 ELISA, experiments were all repeated three times per treatment, for an n ¼ 9 total. A two-way ANOVA was used to evaluate the effects of treatment (DMSO, 1-MeA, Flthn, and the binary PAH mixture) and concentration or time.
The Student-Newman-Keuls test was used for a posteriori comparison of means (P < .05 was considered statistically significant). SigmaPlot (12.3) software (SYSTAT, San Jose, CA) was used for all graphs and statistical analyses.
RESULTS

A LMW PAH Mixture Dysregulates GJIC and Degrades Cx43
Gap junctions are central to the coordination of intracellular signaling events culminating in gene expression. There are simple, rapid, and well established bioassays to measure gap junctional intercellular communication (GJIC) including the scalpel-loaded dye transfer assay (SL/DT). Chronic interruption of these important signaling channels could contribute to the pathogenesis of lung diseases and the SL/DT assay can identify compounds that interrupt these pathways rapidly (Upham, 2011 , but decreased with all treatments at 4 and 8 h of exposure to established 30 min IC 50 concentrations ( Figure 1C ). The inhibition of total Cx43 protein remained after 24 h IC 50 exposure to 1-MeA (25 lM), Flthn (15 lM), and the binary PAH mixture (15 lM) ( Figure 2C ).
Activation of MAPKs by a LMW PAH Mixture
The MAPKs (P38, ERK1/2, and JNK) constitute important signaling pathways that are involved in growth, differentiation, inflammation, apoptosis, and stress responses. We exposed C10 cells to 1-MeA, Flthn, and the binary PAH mixture at the IC 50 doses for the dysregulation of GJIC at 30 min ( Figure 1A ). MAPK activation was investigated by immunoblot analysis of the phosphorylated proteins (Figure 3 ). Cells treated with single PAHs (1-MeA or Flthn), as well as the binary PAH mixture, demonstrated rapid activation of P38 MAPK at 30 min which persisted through 4 h before dissipating at 8 h ( Figure 3A) . At 8 h, pP38 remained significantly elevated by the binary PAH mixture over single PAH treatment of 1-MeA whereas the binary PAH mixture was not significantly different from Flthn. Activation of ERK1/2 was significant at 4 and 8 h with all treatments, but not at 30 min ( Figure 3B ). Phosphorylation of JNK was only significant after 4 h of exposure to the binary PAH mixture and Flthn, but not with treatment of 1-MeA (Supplementary Figure 2A) . MAPK phosphorylation was not observed by immunoblot at 24 h with any MAPKs (Supplementary Figure 2B) at the IC 50 's determined previously for 24 h (see Figure 2 ). According to our results, P38 is the first and most active MAPK in response to PAH exposure with ERK1/2 and JNK activity following after 4 h of exposure to 1-MeA, Flthn, or the binary PAH mixture. All MAPK activity declines by 24 h whereas gap junctions are still dysregulated and Cx43 protein remains decreased.
Inhibition of P38 MAPK Reverses Dysregulation of GJIC by a LMW PAH Mixture
We herein and previously demonstrated that gap junctions are dysregulated at the same time that P38 is activated when C10 cells are exposed to 1-MeA . We expanded on this published observation by determining if P38 was causally linked to PAH-induced dysregulation of GJIC to either Flthn or the binary PAH mixture. Incubation of cells with a P38 MAPK inhibitor, SB203580, prevented the dysregulation of GJIC by PAHs in all treatments and time points from 30 min to 4 h of exposure (Figs. 4A-C). Phosphorylated MAPKAPK-2, which is directly downstream of P38, was decreased with SB203580 pretreatment confirming inhibition of P38 (Supplementary Figure 3A) . After 4 h of exposure to 1-MeA, Flthn, or the binary PAH mixture, the reversal effect of P38 inhibition declined in a time-dependent manner (Figs. 4A-C) and mirrored the decline in phosphorylation of P38 by immunoblot ( Figure 3A) . At 12 h of exposure to the PAHs, the P38 inhibitor no longer prevented the binary PAH mixture and 1-MeA from dysregulating GJIC (Figs. 4A and C). Treatment with Flthn alone remained significantly different from P38 inhibited cells although this effect was minor ( Figure 4B ).
When C10 cells are exposed to 1-MeA, Flthn, or the binary PAH mixture for 30 min, P38 is phosphorylated, GJIC is dysregulated, and total Cx43 protein is unchanged. We determined the role of P38 in the localization of Cx43 by immunocytochemical staining for Cx43 protein ( Figure 5 ). In the control treatment, Cx43 staining localized to the plasma membrane of the cell where it can form gap junctions with neighboring cells (Figure 5 ). The Cx43 staining disappeared from the plasma membrane and increased in the cytoplasm after treatment with 1-MeA or the binary PAH mixture. As previously shown, GJIC is dysregulated at this time point ( Figure 1A ). When P38 is inhibited before treatment with 1-MeA and the binary PAH mixture, Cx43 remains localized to the plasma membrane where it is able to form gap junctions ( Figure 5 ). Inhibition of P38 reversed the dysregulation of GJIC as demonstrated by SL/DT assay (Figure 4) , and prevented the removal of Cx43 from the plasma membrane under PAH treatment ( Figure 5) .
Our results indicated a connection between P38 activity and GJIC, thus we investigated if inhibition of the other MAPKs, ERK1/2, and JNK, would prevent the dysregulation of GJIC by these two LMW PAHs or the binary PAH mixture. Over a time course of 4-8 h, in which ERK and JNK become activated, inhibition of both ERK1/2 and JNK did not prevent the dysregulation of GJIC by the binary PAH mixture (Supplementary Figure 3B) . To further explore the P38-dependent and -independent pathways that become active during exposure to binary PAH mixture, we conducted an Affymetrix gene array in the C10 cells.
P38-Dependent and -Independent Binary PAH Mixture-Induced Transcriptome Changes
We examined the effects of a single PAH (Flthn) or the binary PAH mixture with and without prior P38 inhibition on gene expression in C10 cells at 4 and 8 h. At 4 h of exposure to the binary PAH mixture, 950 genes were altered significantly >1.5-fold (absolute) compared with control (DMSO). Of these genes, 579 were up-regulated whereas 371 were downregulated (Table 1) . Hierarchical clustering displays the differences between Flthn alone and the binary PAH mixture verses P38 inhibition at 4 h ( Figure 6 ). Treatment with Flthn alone altered only 113 genes by >1.5-fold (absolute) (Supplementary Tables 2A and B) . Differences in single exposure to Flthn or the binary PAH mixture are demonstrated by the total number of genes altered with the respective exposures, and in the fold change of these genes (Table 1, Figure 7) . Inhibition of P38 with the binary PAH mixture altered 97 genes >1.5-fold (absolute) when compared with binary PAH mixture alone. Of these, 72 genes were upregulated and 25 genes were down regulated. We identified this group of 97 genes as most likely P38-dependent responses (Table 1) .
Enrichment analysis (Huang da et al., 2009) was performed on the differentially expressed genes (DEGs) to identify statistically significant (FDR < 0.05) overrepresented GO categories and KEGG pathways for both Flthn alone, the binary PAH mixture treatment, as well as to determine P38-dependent and -independent pathways. For the binary PAH mixture treatment, overrepresented KEGG pathways included cytokines/chemokines (mmu04060), steroid biosynthesis (mmu00100), and regulation of protein kinase activity (mmu04115) ( Table 1 ). The immune response GO category listed many genes that were P38-dependent including chemokine (C-C motif) ligand 2 (Ccl2), chemokine (C-C motif) ligand 7 (Ccl7), Interleukin 6 (Il6), Vascular endothelial growth factor A (Vegfa), and Cox2. Of interest, Cox2 was highly induced by the binary PAH mixture and the response was significantly dependent on P38 (Table 1 ). The complete list of DEGs and enrichment analysis results can be found in Supplementary  Tables 2A-H. Regulation of protein kinase activity was an over-represented pathway identified with the binary PAH mixture treatment. P38-dependent genes in this pathway included cyclin-dependent kinase inhibitor 1 (Cdkn1a) and growth arrest and DNA-damage-inducible protein (Gadd45g). Some genes not particularly part of known signaling pathways, but of interest or linked to inflammation, included matrix metallopeptidase 13 (Mmp13), plasminogen activator inhibitor-2 (Serpinb2), early growth response protein 1 (Egr1), and dual specificity phosphatase 6 (Dusps) 1, 5, and 6. Of these genes of interest, Mmp13, Egr1, and Dusp5 were P38-dependent as the fold change was significantly decreased with prior inhibition of P38 (Table 1) . Inflammatory genes that were P38-independent (Table 1 ) included neutrophil chemoattractant chemokine (C-X-C motif) ligand 1 (Cxcl1), chemokine (C-X-C motif) ligand 10 (Cxcl10), tumor necrosis factor receptor superfamily member 1b (Tnfrsf1b) and phospholipase A2, group IVA (Pla2g4a). The steroid biosynthesis pathway was highly significant, down regulated, and largely P38-independent. The steroid biosynthesis genes identified in this pathway are important in cholesterol synthesis and included key cholesterol synthesis enzymes such as 7-dehydrocholesterol reductase (Dhrc7) ( Table 1) .
When the C10s were exposed to the binary PAH mixture for 8 h, a total of 1860 genes were significantly altered by >1.5-fold (absolute) ( Figure 8A ). Of these, 984 genes were upregulated whereas 876 genes were down regulated (see Table 2 for examples; Supplementary Table 2, I-K for complete list). The binary PAH mixture increased fold changes over responses to single PAH exposure as shown in the validated genes ( Figure 8B ). Over-represented KEGG pathways at this time point included steroid biosynthesis (mmu00100) and MAPK signaling (mmu04010). At 8 h, Cox2 remained significantly elevated and this response was highly P38-dependent (Table 2 ). Egr1 was not as substantively upregulated at 8 h indicating this gene may be involved in the early response to these two LMW PAHs and the binary PAH mixture. Additional upregulated genes of interest included Mmps 3, 10, 13, and 28 and fibroblast growth factor 2 (Fgf2). Mmp13 was highly induced by the PAH mixture and P38-dependent. The other Mmps were not P38-dependent. The steroid biosynthesis pathway was the most significantly enriched KEGG pathway identified at 8 h. Similar to the 4 h time point, Dhrc7 ( Figure 8B , Table 2 ), and many other cholesterol pathway genes, were down regulated and P38-independent.
Validation of P38-dependent and -independent genes was conducted by qRTPCR (Tables 1 and 2 bolded genes, Figs. 7 and 8B). If we consider total PAH, the Flthn concentration is 45 lM whereas the binary mixture concentration is 40 lM. Similar to our array results, the binary PAH mixture significantly induces both gene expression and an increase in fold change over single PAH exposure. 
7.29
Serine-type endopeptidase inhibitor activity þþ Genes bolded were validated via RT-PCR. mmu04060, cytokine-cytokine receptor interaction; mmu00100, steroid biosynthesis; mmu05200, pathways in cancer; mmu04115, p53 signaling pathway; mmu04010, MAPK signaling pathway.
LMW Binary PAH Mixture-Induced Cytokine and Matrix Reorganization Protein Release
To identify cytokines produced and released by C10 cells when treated with the binary PAH mixture, we conducted a Raybiotch G1000 series cytokine array. Many inflammatory cytokines were elevated after 8 h of the binary PAH mixture exposure, but were not significant. Cells exposed to the binary PAH mixture produced and significantly released Cxcl1, interleukin 13 (Il-13), Mmp3, tissue inhibitor of metalloproteinase-1 (Timp1), chemokine (C-X-C motif) ligand 5 (Lix), and tyrosine-protein kinase receptor UFO (Axl) (Figure 9 ). P38-dependent responses to the binary PAH mixture included Il-13, Mmp3, and Timp1 whereas expression of Axl, Cxcl1, and Lix were P38-independent. At this time point, we see observed proteins involved in neutrophil chemotaxis (Cxcl1 and Lix) as well as matrix reorganization proteins like Mmp3 and potential EMT marker Axl. Validation of the Cxcl1 response was measured by ELISA (Supplementary Figure  4) . The binary PAH mixture significantly increased Cxcl1 release into the media. This response was P38-independent, validating our observations from both the transcriptomic and proteomic arrays.
DISCUSSION
Exposure of an alveolar type II cell line (C10) to a binary mixture of two LMW PAHs, 1-MeA and Flthn, results in elevated expression of pro-inflammatory genes and proteins that are both dependent and independent of P38 MAPK, thus supporting our FIG. 6 . Hierarchal clustering of genes that differ between the binary PAH mixture, Flthn, P38 inhibition plus LMW PAH, and control. Hierarchal clustering using Partek software of differentially expressed genes that differ between the binary PAH mixture, Flthn, and control (DMSO) in the presence or absence of P38 MAPK inhibitor (P38 inh þ PAH mix) at 4 h treatment. The log base 2 ratio values of normalized pixel intensity data from samples to the average of the normalized pixel intensity data from controls was used. The expression was standardized to mean 0 and standard deviation of 1. Expression bar on bottom (red: genes increased; blue, genes decreased). (Total number of genes increased (579) and decreased (371)). Samples are on the y-axis and clustered genes on the x-axis. Conducted using an n ¼ 3 for all treatment groups.
FIG. 7.
Validation of inflammatory and key pathway genes altered by 4 h with the binary LMW PAH mixture treatment. C10 cells treated with 1-MeA (25 lM), Flthn (45 lM), a binary PAH mixture (40 lM), P38 MAPK inhibitor (P38I) (5 lM) þ a binary PAH mixture (40 lM), and P38I alone (5 lM) at 4 h. Genes are first normalized to 18S followed by comparison to the control (DMSO, 4 h). Mean 6 SE including all replicates with n ¼ 3 per study, replicated three times. *P < .05 compared with DMSO control. þ P < .05 PAH mix compared with P38I þ PAH mix. P38I, P38 inhibitor; PAH mix, binary PAH mixture; 1-MeA, 1-methylanthracene; Flthn, fluoranthene.
overall hypothesis. This study presents the first comprehensive transcriptomic and proteomic data for LMW PAH-induced inflammatory lung effects as well as a characterization of the response to a binary PAH mixture. Our results demonstrate that total PAH, all PAHs in a mixture such as ETS, should be considered when assessing the dysregulation of gap junctions. This finding is supported by results showing additive effects of PAHs on the dysregulation of GJIC in liver cells (Ghoshal et al., 1999) . Contrasting the additive effect of the binary PAH mixture on the dysregulation of gap junctions, our results demonstrate a more synergistic induction of inflammatory genes and cytokine release that was both P38-dependent and -independent. This model of exposing a combination of LMW PAHs in vitro, provides more detailed mechanistic lung inflammatory data, key pathways of exposure, potential therapeutic targets that are P38 dependent and -independent, and possible biomarkers of exposure. (Ali et al., 2016; Wu et al., 2015) , similar to our results. Humans are exposed to both HMW and LMW PAHs at the same time thus combinations of these PAH species need to be explored to identify differences between the groups, key pathways of exposure, and possible interactions that could exacerbate disease.
PAHs and Inflammation
Gap Junctions and Inflammation
Although Cx43 is the major pulmonary connexin, others are also expressed by type I and II cells. These include Cx26, Cx32, Cx37, Cx40, and Cx46 (Johnson and Koval, 2009 ). Out of these connexins, Cx43 is functionally responsible for connecting type I and type II cells and facilitating cell-cell communication (Abraham et al., 2001) . In the lung, gap junctions contribute to the coordination of ciliary beating in epithelial cells, regulate pulmonary surfactant, are critical to physiological Ca 2þ signaling, maintain homeostasis of air surface liquid volume, and alter the lung inflammatory response (Johnson and Koval, 2009; Kuebler et al., 2007; Parthasarathi et al., 2006; Sanderson et al., 1988; Scheckenbach et al., 2011) . Decreased expression of Cx43 and gap junction activity was observed in lung fibroblasts of idiopathic pulmonary fibrosis patients, although the importance of this to the pathogenesis was unclear (Trovato-Salinaro et al., 2006) . Lung epithelial dysregulation of GJIC may be an important, easily measured, and early toxic event with lasting consequences for chronic diseases such as cancer. For example, GJIC activity is inhibited with most classic tumor promoters via alteration of homeostasis and as a result, GJIC suppression is considered an important component of tumor promotion in many types of cancers (eg liver, lung) (Avanzo et al., 2004; Chaudhuri et al., 1993; Ruch et al., 2001) . Additionally, in NSCLC patients, Cx43 is downregulated (Chen et al., 2003) . Thus, acute and chronic (876)). Samples are on the y-axis and clustered genes on the x-axis. Conducted using an n ¼ 3 for all treatment groups. B, C10 cells treated with 1-MeA (25 lM), Flthn (45 lM), a binary PAH mixture (40 lM), P38 inhibitor (P38I) (5 lM) þ a binary PAH mixture (40 lM), and P38I (5 lM) þ DMSO at 8 h.
Mean 6 SE including all replicates with n ¼ 3 per study, replicated three times. *P < .05 compared with control (DMSO). (Tables 1 and 2 , . The role of GJIC in either exacerbating or suppressing inflammation seems to be model, exposure, and cell type specific, but its importance is becoming more evident. This versatile role not only in inflammation, but in the maintenance of lung homeostasis, emphasizes the need for continued research into this critical intercellular signaling pathway.
Activation of P38 MAPK in Lung Disease
P38 MAPK and the other MAPKs, have the potential to directly interact with and phosphorylate Cx43 (Chen et al., 2013; Warn-Cramer et al., 1996) . Inhibition of ERK1/2 and JNK does not reverse dysregulation of GJIC by PAHs indicating that in a type II cell line, P38 MAPK plays the prominent role (Figure 4 , Supplementary Figure 2B ). P38 MAPK is active in inflammatory lung diseases, like COPD, and has been shown to be induced in the lung with exposure to cigarette smoke. Elevated levels of pP38 have also been shown in alveolar macrophages from COPD patients (Renda et al., 2008) . In addition to cigarette smoke, P38 can be activated by oxidative stress, endotoxin, and inflammatory cytokines (Cheng et al., 2011; Chung, 2011; Moretto et al., 2009) . Progress has been made with the efficacy of P38 inhibitors for the treatment of severe COPD showing improvements in patient lung function parameters (MacNee et al., 2013) , however, these are limited in patient numbers and still in clinical trials. Our results identifying key pathways that were P38-dependent or -independent could aid in the identification of new therapeutic targets for COPD and other inflammatory lung diseases where P38 inhibitors have failed.
P38 MAPK-Dependent and -Independent Pathways
Exposure to the binary PAH mixture altered the transcriptome in a P38-dependent and -independent manner. Early P38 linked responses were seen with cytokine and chemokine upregulation at 4 h, whereas the steroid biosynthesis pathway was down regulated and largely P38-independent at both 4 and 8 h (Tables 1  and 2 ). The steroid biosynthesis pathway becomes the most significant KEGG pathway identified at 8 h of the binary PAH mixture treatment. Cholesterol biosynthesis genes dominated this category at both time points. Disruption of the cholesterol biosynthesis pathway has been demonstrated in Xenopus tropicalis exposed to benzo[a]pyrene and could suggest a disruption in lipid metabolism, signaling, or accumulation (Regnault et al., 2014) . Cigarette smoke can also cause lipid accumulation in alveolar macrophages (Morissette et al., 2015) . This disruption of steroid biosynthesis could have impacts on surfactant production or makeup, lipid accumulation, and signaling.
Cox-2 is highly upregulated after binary PAH mixture exposure at both 4 and 8 h. Rat liver cell and endothelial cell exposure to LMW PAHs has shown rapid release of arachidonic acid which is converted by cytosolic phospholipase A 2 . Cytosolic phospholipase A 2 is also upregulated at 4 h exposure to the binary PAH mixture. Both of these events are directly upstream of Cox-2 and provide a potential mechanism for LMW PAH action on type II cells Tithof et al., 2002; Upham et al., 2008) . At 8 h of exposure, most significantly altered genes are P38-independent with the exception of Mmp13 and Cox2. Of the Mmps altered by the binary PAH mixture, Mmp13 was the only P38-dependent gene and the most highly upregulated.
The cytokine array provided evidence that transcriptomic pro-inflammatory responses from exposure to the binary PAH mixture are being translated to protein and released from the C10 cells. These proteins included cytokines, matrix altering proteins like Mmps, and neutrophil chemotactic factors. Production and release of Cxc1 (Supplementary Figure 4) provides additional evidence and validation.
Tissue remodeling and repair is thought to be critical in the progression of COPD (Hogg et al., 2004) . Of the Mmps identified in this study, Mmp-13 was the most highly induced after the FIG. 9 . Inflammatory protein release by C10 cells treated with a binary PAH mixture. Cells were treated with the binary PAH mixture (40 lM) or pre-treatment with a P38 inhibitor (SB203580, 5 lM 1 h prior) for 8 h before media was collected and processed for a Raybiotech cytokine array. Significant increases of Lix, Axl, Mmp13, Il-13, Cxcl1, and Timp1. Mean 6 SE presented with n ¼ 3. *P < .05 compared with control (DMSO). binary PAH mixture treatment and this response was P38-dependent. Patients with COPD also have increased protein expression of Mmp-13 in type II cells and macrophages when compared with healthy individuals (Lee et al., 2009) . The C10 cells also released Mmp-3 when stimulated with the binary PAH mixture treatment. This response was P38-dependent. Additionally, an Mmp inhibitor we found decreased in C10 cells exposed to the binary PAH mixture, Timp-1, is also reduced in patients with COPD (Gosselink et al., 2010) . This study provides additional evidence that type II cells serve a potentially important role in the repair and remodeling process and could be targeted for therapeutics.
CONCLUSION
Smokers and non-smokers are exposed to substantial amounts of LMW PAHs, which are the most abundant PAHs of ambient air in both indoor and outdoor environments (Bostrom et al., 2002; Li et al., 2005) . However, there is little information on the adverse health effects of these LMW PAHs on pulmonary inflammation and disease. In addition, due to anticipated increases of secondhand marijuana smoke exposure in the U.S., such as in Colorado, California, Oregon, Nevada, Massachusetts, Alaska and Washington, improving our understanding of these compounds is critical. We used a transcriptomic and proteomic approach to study the inflammatory effects of these common contaminants of secondhand smoke and ambient air on lung cells to identify key molecular pathways. A mixture of two LMW PAHs resulted in a greatly enhanced, potentially synergistic, induction of proinflammatory genes when compared with exposure of a single PAH (1-MeA or Flthn). We also identified molecular pathways that were dependent and independent of P38 MAPK activation. This study expands on our previous work showing structure and function relationships between LMW PAHs and should offer insight into new biomarkers for assessments of exposure, novel pathways to target for therapeutics, and mechanisms of pathogenesis for lung diseases, such as COPD.
SUPPLEMENTARY DATA
Supplementary data are available at Toxicological Sciences online.
